FDA Clearance Tracker · K230205
Veloxion System
Last checked: Nov 19, 2026Latest source record: Feb 24, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Feb 24, 2023
Substantially Equivalent
Time to decision
30 days
Received Jan 25, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K230205
- Device name
- Veloxion System
- Applicant
- Corinth Medtech, Inc.
- Applicant location
- San Jose, CA
- Received
- Jan 25, 2023
- Decided
- Feb 24, 2023
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Resectoscope (FJL)
- Device class
- Class II
- Regulation
- 21 CFR 876.1500
- Specialty
- GI, Urology & NephrologyUrology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code FJL. The earliest in FDA's data is K761242, decided Dec 16, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K230205
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Corinth Medtech, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K191341 · Decided Jun 13, 2019 · 24 days after receipt
Device type: Resectoscope (FJL) · GI, Urology & Nephrology
K191335 · Decided Jun 6, 2019 · 20 days after receipt
Device type: Hysteroscope (And Accessories) (HIH) · Obstetrics & Gynecology
K190113 · Decided Apr 24, 2019 · 90 days after receipt
Device type: Hysteroscope (And Accessories) (HIH) · Obstetrics & Gynecology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.